chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Injection site erythema, Injection site irritation
Clinical narrative: Fatigue, pain at injection site and soreness under left arm starting around 11pm on 11Jun2021; fatigue and underarm soreness and still continuing today (14Jun2021); dizziness starting around 6am on 12Jun2021 and still continuing today (14Jun2021); fever and chills starting around 8am on 12Jun2021 and subsiding by around 9am on 13Jun2021; raised, red/irritated skin around injection site, in shape of band-aid that was applied after injection, observed 13Jun2021 and still persisting as of 14Jun2021; increased dizziness and racing heart beat starting morning of 14Jun2021 and still continuing.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity, Palpitations, Pyrexia, Rash papular
Clinical narrative: Fatigue, pain at injection site and soreness under left arm starting around 11pm on 11Jun2021; fatigue and underarm soreness and still continuing today (14Jun2021); dizziness starting around 6am on 12Jun2021 and still continuing today (14Jun2021); fever and chills starting around 8am on 12Jun2021 and subsiding by around 9am on 13Jun2021; raised, red/irritated skin around injection site, in shape of band-aid that was applied after injection, observed 13Jun2021 and still persisting as of 14Jun2021; increased dizziness and racing heart beat starting morning of 14Jun2021 and still continuing.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue
Clinical narrative: Severe weakness in body, tired, dizziness, spareness,
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Bundle branch block right, Chest X-ray abnormal, Chest pain, Computerised tomogram thorax abnormal
Clinical narrative: Sunday, January 10 2021 around 1900. Suffered from chest pain. EKG showed STEMI. Chest x-ray showed 20% pneumothorax. Treated with nonrebreather 15L for several hours. Follow-up EKG shows retaining right bundle branch block.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Cystic lung disease, Electrocardiogram abnormal, Pneumothorax
Clinical narrative: Sunday, January 10 2021 around 1900. Suffered from chest pain. EKG showed STEMI. Chest x-ray showed 20% pneumothorax. Treated with nonrebreather 15L for several hours. Follow-up EKG shows retaining right bundle branch block.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus (high-pitched ringing) in the right ear
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac flutter, Cardiac stress test, Cardioversion, Chest discomfort
Clinical narrative: Dizziness, "flutters" (heart palpitations), chest heaviness, short of breath.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Echocardiogram abnormal, Palpitations, Troponin increased
Clinical narrative: Dizziness, "flutters" (heart palpitations), chest heaviness, short of breath.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Atrioventricular block, Blood test abnormal, Bone pain, Cardiovascular examination, Chest X-ray
Clinical narrative: Left arm started hurting. It hurt for 2 days. Then my right and left arm started hurting. this went on for another 2 days. then both my arms ,across my back and both hands went numb. Went to emergency room. They did test. Said i had blocked heart artery. They removed blockage. I was in serve pain, It felt like my bones was breaking. I end up going to the doctor 2 days in a row. The doctors think that the vaccine may have trigger that reaction.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging, Pain, Pain in extremity
Clinical narrative: Left arm started hurting. It hurt for 2 days. Then my right and left arm started hurting. this went on for another 2 days. then both my arms ,across my back and both hands went numb. Went to emergency room. They did test. Said i had blocked heart artery. They removed blockage. I was in serve pain, It felt like my bones was breaking. I end up going to the doctor 2 days in a row. The doctors think that the vaccine may have trigger that reaction.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Chest discomfort, Dyspnoea, Fatigue, Headache
Clinical narrative: Tightening around heart and chest area. Heart feels constricted and squeezed/tightening. Have a hard time trying to breath deeply. Headaches, felt fatigued, and  heart hurts,, which lasted for 2 days.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Aldolase, Anti-VGCC antibody, Antiacetylcholine receptor antibody, Antibody test, Blood cortisol
Clinical narrative: progressive weakness affecting all limbs and ventilation; diagnosed with acute inflammatory demyelinating polyneuropathy
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lead, CSF test, Herpes simplex test, Mechanical ventilation, Muscular weakness
Clinical narrative: progressive weakness affecting all limbs and ventilation; diagnosed with acute inflammatory demyelinating polyneuropathy
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Subacute inflammatory demyelinating polyneuropathy, Treponema test
Clinical narrative: progressive weakness affecting all limbs and ventilation; diagnosed with acute inflammatory demyelinating polyneuropathy
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Heart rate decreased, Heart rate increased, Loss of consciousness
Clinical narrative: Client experienced loss of consciousness for approximately 20 seconds. Reported feeling weakness, light-headed. Client had loss of color to face, increased pulse followed by reduced pulse, that normalized on its own. After approximately 25-30 minutes client was feeling better, pulse normalized, color returned to face and he reported improvement in his symptoms.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Pallor
Clinical narrative: Client experienced loss of consciousness for approximately 20 seconds. Reported feeling weakness, light-headed. Client had loss of color to face, increased pulse followed by reduced pulse, that normalized on its own. After approximately 25-30 minutes client was feeling better, pulse normalized, color returned to face and he reported improvement in his symptoms.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Mother described a rash the size of a baseball on pt's left thigh which was red, swollen and warm.  Provider suggested Benadryl and rash resolved after a few days. *another pt had same vaccinations- same reaction DTap (common)
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cellulite, Injection site erythema, Injection site induration, Injection site rash, Injection site warmth
Clinical narrative: Pt received Dtap on 4/7/21 and grandmother (guardian) called Thursday to say she took pt to ER Wednesday evening due to a large warm, hard, red rash on pt's left leg. Pt treated ER for cellulite. Slowly resolving rash. Rash described as large as a softball. *another pt had reaction- Dtap common factor.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac failure congestive, Cardiac tamponade, Computerised tomogram abdomen, Computerised tomogram thorax
Clinical narrative: Developed Cardiac Tampanade and Pulmonary CNusion both lungs Treated at Hospital I was hospitalized for 8 days, I improved, but still have CHF UPDATED JUNE 13, 2021 GREATLY IMPROVED
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Pulmonary contusion, White blood cell count increased
Clinical narrative: Developed Cardiac Tampanade and Pulmonary CNusion both lungs Treated at Hospital I was hospitalized for 8 days, I improved, but still have CHF UPDATED JUNE 13, 2021 GREATLY IMPROVED
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: prolonged intermittent pain in arm (upper arm)
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cough, Dyspnoea, Headache, Malaise
Clinical narrative: On 6-12-21 patient was not feeling well was in bed with head-ache, fever, pain in stomach, & nausea. On 6-13-21 she had a rash on her neck & shoulder. On 6-14-21 she is experiencing shortness of breath and also cough.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Rash
Clinical narrative: On 6-12-21 patient was not feeling well was in bed with head-ache, fever, pain in stomach, & nausea. On 6-13-21 she had a rash on her neck & shoulder. On 6-14-21 she is experiencing shortness of breath and also cough.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Cardiac stress test, Catheterisation cardiac, Chest pain, Decreased activity
Clinical narrative: Precipatious decline in cardio health to include sever and continuing chest pain and forcing a reduction in activity as well as specialty cardiac care.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram
Clinical narrative: Precipatious decline in cardio health to include sever and continuing chest pain and forcing a reduction in activity as well as specialty cardiac care.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Peripheral swelling
Clinical narrative: Commonly known as SIRVA ( Shoulder Injury Related to Vaccine Injection). Starting the day after injection and continuing through present ( 4+months), intense pain when moving or stressing left shoulder. Similar to what one would expect from a serious ACL injury. I felt a "pop" during the injection, but did not connect it to this type of injury until after future reading.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site joint movement impairment, Injection site reaction, Pain, Sensory disturbance, Shoulder injury related to vaccine administration
Clinical narrative: Commonly known as SIRVA ( Shoulder Injury Related to Vaccine Injection). Starting the day after injection and continuing through present ( 4+months), intense pain when moving or stressing left shoulder. Similar to what one would expect from a serious ACL injury. I felt a "pop" during the injection, but did not connect it to this type of injury until after future reading.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Dizziness, Feeling abnormal, Headache
Clinical narrative: Pt was in her usual state of health until January, when she had mild symptoms of covid 19. She quarantined for two weeks, then received the first dose of covid 19 vaccine. Following the vaccine, husband noticed gradual decline. Started with trouble walking and gait instability, slurred speech, swelling in feet and legs, dizziness, and SOB. She went to neurologist, had MRI that read "patchy white matter disease" with EEG consistent with encephalopathy. She also went to physical therapy to help with her strength and gait. She would be tired after but could still move joints with assistance.  In the last 6 weeks, pt seems to have gotten even worse. She does not even move her joint, barely moves fingers and toes, has intermittent slurred speech and episodes of gibberish. She 24 hour care. She was discharged from PT due to inability to progress more. She is currently being treated at  Hospital
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Disorganised speech, Dizziness, Dysarthria, Dyspnoea
Clinical narrative: Pt was in her usual state of health until January, when she had mild symptoms of covid 19. She quarantined for two weeks, then received the first dose of covid 19 vaccine. Following the vaccine, husband noticed gradual decline. Started with trouble walking and gait instability, slurred speech, swelling in feet and legs, dizziness, and SOB. She went to neurologist, had MRI that read "patchy white matter disease" with EEG consistent with encephalopathy. She also went to physical therapy to help with her strength and gait. She would be tired after but could still move joints with assistance.  In the last 6 weeks, pt seems to have gotten even worse. She does not even move her joint, barely moves fingers and toes, has intermittent slurred speech and episodes of gibberish. She 24 hour care. She was discharged from PT due to inability to progress more. She is currently being treated at  Hospital
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram abnormal, Encephalopathy, Gait disturbance, Joint stiffness, Magnetic resonance imaging abnormal
Clinical narrative: Pt was in her usual state of health until January, when she had mild symptoms of covid 19. She quarantined for two weeks, then received the first dose of covid 19 vaccine. Following the vaccine, husband noticed gradual decline. Started with trouble walking and gait instability, slurred speech, swelling in feet and legs, dizziness, and SOB. She went to neurologist, had MRI that read "patchy white matter disease" with EEG consistent with encephalopathy. She also went to physical therapy to help with her strength and gait. She would be tired after but could still move joints with assistance.  In the last 6 weeks, pt seems to have gotten even worse. She does not even move her joint, barely moves fingers and toes, has intermittent slurred speech and episodes of gibberish. She 24 hour care. She was discharged from PT due to inability to progress more. She is currently being treated at  Hospital
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Peripheral swelling, White matter lesion
Clinical narrative: Pt was in her usual state of health until January, when she had mild symptoms of covid 19. She quarantined for two weeks, then received the first dose of covid 19 vaccine. Following the vaccine, husband noticed gradual decline. Started with trouble walking and gait instability, slurred speech, swelling in feet and legs, dizziness, and SOB. She went to neurologist, had MRI that read "patchy white matter disease" with EEG consistent with encephalopathy. She also went to physical therapy to help with her strength and gait. She would be tired after but could still move joints with assistance.  In the last 6 weeks, pt seems to have gotten even worse. She does not even move her joint, barely moves fingers and toes, has intermittent slurred speech and episodes of gibberish. She 24 hour care. She was discharged from PT due to inability to progress more. She is currently being treated at  Hospital
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Eye movement disorder, Fatigue, Speech disorder
Clinical narrative: received the vaccine. Not even 5 minutes after receiving it she passed out. Everyday since that vaccine she faints. She starts sweating very bad and then she faints for about 10 to 15 seconds. She faints at school, on the bus, at the prom. Not a day goes by that she doesn't. I wish that I had not made her get it. She was in the hospital overnight. She has now seen a cardiologist and soon a neurologist.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: received the vaccine. Not even 5 minutes after receiving it she passed out. Everyday since that vaccine she faints. She starts sweating very bad and then she faints for about 10 to 15 seconds. She faints at school, on the bus, at the prom. Not a day goes by that she doesn't. I wish that I had not made her get it. She was in the hospital overnight. She has now seen a cardiologist and soon a neurologist.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiovascular evaluation, Hyperhidrosis, Loss of consciousness, Syncope
Clinical narrative: received the vaccine. Not even 5 minutes after receiving it she passed out. Everyday since that vaccine she faints. She starts sweating very bad and then she faints for about 10 to 15 seconds. She faints at school, on the bus, at the prom. Not a day goes by that she doesn't. I wish that I had not made her get it. She was in the hospital overnight. She has now seen a cardiologist and soon a neurologist.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiokeratoma, Body height decreased, Dizziness
Clinical narrative: A severe rash developed after five days on the bottom of my scrotum. For three weeks there was severe pain when walking . Was given a blood test for herpes, which was negative on April 8. Was told it would not show up in blood for up to six months. Went to a Urologist on June 10, 2021. Was told this reaction was caused by the vaccines. The incident lasted 40 days before the rash disappeared
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood immunoglobulin G normal, Herpes simplex test negative, Pain, Scrotal dermatitis
Clinical narrative: A severe rash developed after five days on the bottom of my scrotum. For three weeks there was severe pain when walking . Was given a blood test for herpes, which was negative on April 8. Was told it would not show up in blood for up to six months. Went to a Urologist on June 10, 2021. Was told this reaction was caused by the vaccines. The incident lasted 40 days before the rash disappeared
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Neuropathy peripheral, Pain, Pain in extremity
Clinical narrative: neuropathy in her extremities/neuropathy had spread and increased/neuropathy; numbness in fingertips/numbness on the right side of face/losing sensation for cold and hot in hands and feet; bad pain/pain/pain was so bad; burning sensation/burning and the pain in feet; hands and legs were tingling; burning and the pain in feet; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0150; Expiration Date: 31Jul2021), dose 1 via an unspecified route of administration, administered in arm right on 07Apr2021 (at the age of 64-year-old) as single dose for COVID-19 immunisation. Medical history included some minimal nerve damage manifesting as a loss of sensation to coldness and numbness in big toe. Concomitant medication included gabapentin for nerve injury/nerve damage. Patient developed neuropathy in her extremities after getting the first dose of the COVID-19 vaccines. She explained she had bad pain and described it as a burning sensation. She added her hands and legs were tingling, she had numbness in fingertips and numbness on the right side of face.  She specified it had not gone away and this coming Wednesday would make it eight weeks with her symptoms. She specified however, she had no issue in hands, arms and legs before vaccination. She explained since her vaccination, the neuropathy had spread and increased plus she was experiencing pain. She repeated prior to the shot, nothing was wrong with her. Patient had the first one on 07Apr2021 and developed neuropathy within 18 hours (on 08Apr2021). Started developing neuropathy. Now it's being almost 8 weeks and still had, it had not gone away and didn't get the second dose because the pain was so bad the burning and the pain in feet. Wednesday will be 8 weeks. Patient was losing sensation for cold and hot in hands and feet but had no pain. Patient stated there was no treatment. All AEs were onset on 08Apr2021. The outcome of the events was not recovered.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Hypoaesthesia, Neuropathy peripheral, Pain, Pain in extremity
Clinical narrative: neuropathy in her extremities/neuropathy had spread and increased/neuropathy; numbness in fingertips/numbness on the right side of face/losing sensation for cold and hot in hands and feet; bad pain/pain/pain was so bad; burning sensation/burning and the pain in feet; hands and legs were tingling; burning and the pain in feet; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0150; Expiration Date: 31Jul2021), dose 1 via an unspecified route of administration, administered in arm right on 07Apr2021 (at the age of 64-year-old) as single dose for COVID-19 immunisation. Medical history included some minimal nerve damage manifesting as a loss of sensation to coldness and numbness in big toe. Concomitant medication included gabapentin for nerve injury/nerve damage. Patient developed neuropathy in her extremities after getting the first dose of the COVID-19 vaccines. She explained she had bad pain and described it as a burning sensation. She added her hands and legs were tingling, she had numbness in fingertips and numbness on the right side of face.  She specified it had not gone away and this coming Wednesday would make it eight weeks with her symptoms. She specified however, she had no issue in hands, arms and legs before vaccination. She explained since her vaccination, the neuropathy had spread and increased plus she was experiencing pain. She repeated prior to the shot, nothing was wrong with her. Patient had the first one on 07Apr2021 and developed neuropathy within 18 hours (on 08Apr2021). Started developing neuropathy. Now it's being almost 8 weeks and still had, it had not gone away and didn't get the second dose because the pain was so bad the burning and the pain in feet. Wednesday will be 8 weeks. Patient was losing sensation for cold and hot in hands and feet but had no pain. Patient stated there was no treatment. All AEs were onset on 08Apr2021. The outcome of the events was not recovered.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: neuropathy in her extremities/neuropathy had spread and increased/neuropathy; numbness in fingertips/numbness on the right side of face/losing sensation for cold and hot in hands and feet; bad pain/pain/pain was so bad; burning sensation/burning and the pain in feet; hands and legs were tingling; burning and the pain in feet; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EW0150; Expiration Date: 31Jul2021), dose 1 via an unspecified route of administration, administered in arm right on 07Apr2021 (at the age of 64-year-old) as single dose for COVID-19 immunisation. Medical history included some minimal nerve damage manifesting as a loss of sensation to coldness and numbness in big toe. Concomitant medication included gabapentin for nerve injury/nerve damage. Patient developed neuropathy in her extremities after getting the first dose of the COVID-19 vaccines. She explained she had bad pain and described it as a burning sensation. She added her hands and legs were tingling, she had numbness in fingertips and numbness on the right side of face.  She specified it had not gone away and this coming Wednesday would make it eight weeks with her symptoms. She specified however, she had no issue in hands, arms and legs before vaccination. She explained since her vaccination, the neuropathy had spread and increased plus she was experiencing pain. She repeated prior to the shot, nothing was wrong with her. Patient had the first one on 07Apr2021 and developed neuropathy within 18 hours (on 08Apr2021). Started developing neuropathy. Now it's being almost 8 weeks and still had, it had not gone away and didn't get the second dose because the pain was so bad the burning and the pain in feet. Wednesday will be 8 weeks. Patient was losing sensation for cold and hot in hands and feet but had no pain. Patient stated there was no treatment. All AEs were onset on 08Apr2021. The outcome of the events was not recovered.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Chest pain, Chills, Computerised tomogram coronary artery normal, Echocardiogram
Clinical narrative: Developed severe CP 3 days after vaccine lasting 2 hours and went away with Motrin.  Awakened day #4 with severe CP and went to ER where dx with acute myopericarditis based on symptoms, EKG and hsTroponin >6000.  Admitted and given IV toradol, tramadol, colchicine and high dose Motrin.  due to elevated hsTrop, ongoing CP and 3mm ST elevation on EKG underwent coronary CTA>>normal and then cardiac MRI showing acute myopericarditis.  Had CP for 1 months that eventually resolved after changing to Indomethacin high dose.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ejection fraction, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Fatigue, Magnetic resonance imaging heart
Clinical narrative: Developed severe CP 3 days after vaccine lasting 2 hours and went away with Motrin.  Awakened day #4 with severe CP and went to ER where dx with acute myopericarditis based on symptoms, EKG and hsTroponin >6000.  Admitted and given IV toradol, tramadol, colchicine and high dose Motrin.  due to elevated hsTrop, ongoing CP and 3mm ST elevation on EKG underwent coronary CTA>>normal and then cardiac MRI showing acute myopericarditis.  Had CP for 1 months that eventually resolved after changing to Indomethacin high dose.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Pyrexia, Red blood cell sedimentation rate normal, Troponin T normal
Clinical narrative: Developed severe CP 3 days after vaccine lasting 2 hours and went away with Motrin.  Awakened day #4 with severe CP and went to ER where dx with acute myopericarditis based on symptoms, EKG and hsTroponin >6000.  Admitted and given IV toradol, tramadol, colchicine and high dose Motrin.  due to elevated hsTrop, ongoing CP and 3mm ST elevation on EKG underwent coronary CTA>>normal and then cardiac MRI showing acute myopericarditis.  Had CP for 1 months that eventually resolved after changing to Indomethacin high dose.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram normal, C-reactive protein increased, Cardiac imaging procedure abnormal, Chest pain, Echocardiogram normal
Clinical narrative: Developed severe CP 3 days after vaccine lasting 2 hours and went away with Motrin.  Awakened day #4 with severe CP and went to ER where dx with acute myopericarditis based on symptoms, EKG and hsTroponin >6000.  Admitted and given IV toradol, tramadol, colchicine and high dose Motrin.  due to elevated hsTrop, ongoing CP and 3mm ST elevation on EKG underwent coronary CTA>>normal and then cardiac MRI showing acute myopericarditis.  Had CP for 1 months that eventually resolved after changing to Indomethacin high dose.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Electrocardiogram ST segment elevation, Myocarditis, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: Developed severe CP 3 days after vaccine lasting 2 hours and went away with Motrin.  Awakened day #4 with severe CP and went to ER where dx with acute myopericarditis based on symptoms, EKG and hsTroponin >6000.  Admitted and given IV toradol, tramadol, colchicine and high dose Motrin.  due to elevated hsTrop, ongoing CP and 3mm ST elevation on EKG underwent coronary CTA>>normal and then cardiac MRI showing acute myopericarditis.  Had CP for 1 months that eventually resolved after changing to Indomethacin high dose.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Patient presented to the ED in the early morning of 5/27/21 complaining of nausea/vomiting/diarrhea since she received her second dose of COVID vaccine on 5/5.   Patient states that prior to coming to the ED she had a syncopal episode preceded by nausea, diaphoresis, paresthesias, tinnitus and lightheadedness.  She stated that she had started to experience shortness of breath the intermittently a week before she was seen in the ED.  Patient was found to have a massive saddle PE with extensive bilateral pulmonary embolism.  Patient's BP in ED was low at 94/52 and her HR was 130.  Patient was given fluid boluses, started on anticoagulants and admitted to the critical care unit.  Later on 5/27, patient underwent a mechanical thrombectomy which was successful.  Patient was then transitioned to apixaban and discharged.   (Patient had previously been seen in the ED on  5/8/21 for complaints of nausea, vomiting and diarrhea since receiving her COVID vaccine on 5/5.  Patient was given IV fluids and ondansetron and felt better.  She was prescribed ondansetron on discharge from the ED.)
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood glucose increased, Blood lactic acid, Brain natriuretic peptide increased, Diarrhoea
Clinical narrative: Patient presented to the ED in the early morning of 5/27/21 complaining of nausea/vomiting/diarrhea since she received her second dose of COVID vaccine on 5/5.   Patient states that prior to coming to the ED she had a syncopal episode preceded by nausea, diaphoresis, paresthesias, tinnitus and lightheadedness.  She stated that she had started to experience shortness of breath the intermittently a week before she was seen in the ED.  Patient was found to have a massive saddle PE with extensive bilateral pulmonary embolism.  Patient's BP in ED was low at 94/52 and her HR was 130.  Patient was given fluid boluses, started on anticoagulants and admitted to the critical care unit.  Later on 5/27, patient underwent a mechanical thrombectomy which was successful.  Patient was then transitioned to apixaban and discharged.   (Patient had previously been seen in the ED on  5/8/21 for complaints of nausea, vomiting and diarrhea since receiving her COVID vaccine on 5/5.  Patient was given IV fluids and ondansetron and felt better.  She was prescribed ondansetron on discharge from the ED.)
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Haemoglobin decreased, Hyperhidrosis, Hypotension
Clinical narrative: Patient presented to the ED in the early morning of 5/27/21 complaining of nausea/vomiting/diarrhea since she received her second dose of COVID vaccine on 5/5.   Patient states that prior to coming to the ED she had a syncopal episode preceded by nausea, diaphoresis, paresthesias, tinnitus and lightheadedness.  She stated that she had started to experience shortness of breath the intermittently a week before she was seen in the ED.  Patient was found to have a massive saddle PE with extensive bilateral pulmonary embolism.  Patient's BP in ED was low at 94/52 and her HR was 130.  Patient was given fluid boluses, started on anticoagulants and admitted to the critical care unit.  Later on 5/27, patient underwent a mechanical thrombectomy which was successful.  Patient was then transitioned to apixaban and discharged.   (Patient had previously been seen in the ED on  5/8/21 for complaints of nausea, vomiting and diarrhea since receiving her COVID vaccine on 5/5.  Patient was given IV fluids and ondansetron and felt better.  She was prescribed ondansetron on discharge from the ED.)
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Nausea, Paraesthesia, Platelet count decreased, Pulmonary embolism
Clinical narrative: Patient presented to the ED in the early morning of 5/27/21 complaining of nausea/vomiting/diarrhea since she received her second dose of COVID vaccine on 5/5.   Patient states that prior to coming to the ED she had a syncopal episode preceded by nausea, diaphoresis, paresthesias, tinnitus and lightheadedness.  She stated that she had started to experience shortness of breath the intermittently a week before she was seen in the ED.  Patient was found to have a massive saddle PE with extensive bilateral pulmonary embolism.  Patient's BP in ED was low at 94/52 and her HR was 130.  Patient was given fluid boluses, started on anticoagulants and admitted to the critical care unit.  Later on 5/27, patient underwent a mechanical thrombectomy which was successful.  Patient was then transitioned to apixaban and discharged.   (Patient had previously been seen in the ED on  5/8/21 for complaints of nausea, vomiting and diarrhea since receiving her COVID vaccine on 5/5.  Patient was given IV fluids and ondansetron and felt better.  She was prescribed ondansetron on discharge from the ED.)
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope, Thrombectomy, Tinnitus, Troponin, Vomiting
Clinical narrative: Patient presented to the ED in the early morning of 5/27/21 complaining of nausea/vomiting/diarrhea since she received her second dose of COVID vaccine on 5/5.   Patient states that prior to coming to the ED she had a syncopal episode preceded by nausea, diaphoresis, paresthesias, tinnitus and lightheadedness.  She stated that she had started to experience shortness of breath the intermittently a week before she was seen in the ED.  Patient was found to have a massive saddle PE with extensive bilateral pulmonary embolism.  Patient's BP in ED was low at 94/52 and her HR was 130.  Patient was given fluid boluses, started on anticoagulants and admitted to the critical care unit.  Later on 5/27, patient underwent a mechanical thrombectomy which was successful.  Patient was then transitioned to apixaban and discharged.   (Patient had previously been seen in the ED on  5/8/21 for complaints of nausea, vomiting and diarrhea since receiving her COVID vaccine on 5/5.  Patient was given IV fluids and ondansetron and felt better.  She was prescribed ondansetron on discharge from the ED.)
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthritis, Back pain, C-reactive protein, C-reactive protein increased, Erythema nodosum
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Investigation, Myalgia
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Pain, Red blood cell sedimentation rate, Red blood cell sedimentation rate increased, SARS-CoV-2 test
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Arthritis, Back pain, C-reactive protein increased, Condition aggravated
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Crying, Dermatitis, Erythema nodosum, Fatigue, Gait disturbance
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hypersensitivity, Illness, Immunology test normal
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza like illness, Insomnia, Joint fluid drainage, Joint swelling, Moaning
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Myalgia, Neck pain, Pain, Pain in extremity
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, Respiratory tract infection, Urticaria, Vaccination complication
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, Gait disturbance, Joint swelling, Lymphocyte count increased, Neutrophil count increased
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: Joint swelling that began in the knees and progressed to the point that the patient could not walk with elevated ESR and CRP not controlled after three rounds of oral steroids. Patient continues to have symptoms which now includes swelling of right ankle and top of right foot preventing her from walking as of 6-15-2021
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram normal, Aphasia, Asthenia, Blood pressure increased, Blood test normal
Clinical narrative: loss of speech; elevated blood pressure; paralysis (hemiplegia) of the right side of my body; full body weakness; This is a spontaneous report from a contactable consumer (patient). A 42-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration, in left arm on 17Apr2021 15:00 (at the age of 42-years-old) as 1st dose, single dose for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Device date reported 09Jun2021. Medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. Known allergies were reported guava's, latex, covid-19 vaccine (MRNA, Bnt162b2, Lnp-S), diphenhydramine, ketorolac, prochlorperazine. Concomitant medications included cetirizine and hydroxyzine both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any vaccines within four weeks prior to the vaccination. On 17Apr2021 15:15, the patient experienced extreme and debilitating symptoms including paralysis (hemiplegia) of the right side of his body, full body weakness, loss of speech and elevated blood pressure that have been present and persisting since immediately following his first dose. Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, disability, or permanent damage. 08 days of hospitalisation were reported. Treatment received for the adverse event was blood pressure medications and PT. The patient underwent lab tests and procedures which included Covid-19 RNA, qualitative (M2000) nasal swab, negative on 18Apr2021, POCT COVID-19 RNA, Qualitative, nasal swab negative on 18Apr2021, COVID19 RNA, QUALITATIVE(M2000), nasal swab negative on 22Apr2021 and POCT COVID-19 RNA, Qualitative, nasal swab negative on 15May2021.The outcome of events was Not recovered .  Information on Lot/Batch number was available. Additional information has been requested
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cognitive test, Computerised tomogram normal, Discomfort, Dizziness, Dysgraphia
Clinical narrative: loss of speech; elevated blood pressure; paralysis (hemiplegia) of the right side of my body; full body weakness; This is a spontaneous report from a contactable consumer (patient). A 42-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration, in left arm on 17Apr2021 15:00 (at the age of 42-years-old) as 1st dose, single dose for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Device date reported 09Jun2021. Medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. Known allergies were reported guava's, latex, covid-19 vaccine (MRNA, Bnt162b2, Lnp-S), diphenhydramine, ketorolac, prochlorperazine. Concomitant medications included cetirizine and hydroxyzine both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any vaccines within four weeks prior to the vaccination. On 17Apr2021 15:15, the patient experienced extreme and debilitating symptoms including paralysis (hemiplegia) of the right side of his body, full body weakness, loss of speech and elevated blood pressure that have been present and persisting since immediately following his first dose. Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, disability, or permanent damage. 08 days of hospitalisation were reported. Treatment received for the adverse event was blood pressure medications and PT. The patient underwent lab tests and procedures which included Covid-19 RNA, qualitative (M2000) nasal swab, negative on 18Apr2021, POCT COVID-19 RNA, Qualitative, nasal swab negative on 18Apr2021, COVID19 RNA, QUALITATIVE(M2000), nasal swab negative on 22Apr2021 and POCT COVID-19 RNA, Qualitative, nasal swab negative on 15May2021.The outcome of events was Not recovered .  Information on Lot/Batch number was available. Additional information has been requested
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram, Erythema, Facial paralysis, Fatigue, Gait disturbance
Clinical narrative: loss of speech; elevated blood pressure; paralysis (hemiplegia) of the right side of my body; full body weakness; This is a spontaneous report from a contactable consumer (patient). A 42-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration, in left arm on 17Apr2021 15:00 (at the age of 42-years-old) as 1st dose, single dose for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Device date reported 09Jun2021. Medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. Known allergies were reported guava's, latex, covid-19 vaccine (MRNA, Bnt162b2, Lnp-S), diphenhydramine, ketorolac, prochlorperazine. Concomitant medications included cetirizine and hydroxyzine both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any vaccines within four weeks prior to the vaccination. On 17Apr2021 15:15, the patient experienced extreme and debilitating symptoms including paralysis (hemiplegia) of the right side of his body, full body weakness, loss of speech and elevated blood pressure that have been present and persisting since immediately following his first dose. Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, disability, or permanent damage. 08 days of hospitalisation were reported. Treatment received for the adverse event was blood pressure medications and PT. The patient underwent lab tests and procedures which included Covid-19 RNA, qualitative (M2000) nasal swab, negative on 18Apr2021, POCT COVID-19 RNA, Qualitative, nasal swab negative on 18Apr2021, COVID19 RNA, QUALITATIVE(M2000), nasal swab negative on 22Apr2021 and POCT COVID-19 RNA, Qualitative, nasal swab negative on 15May2021.The outcome of events was Not recovered .  Information on Lot/Batch number was available. Additional information has been requested
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hemiplegia, Lethargy, Loss of personal independence in daily activities, Magnetic resonance imaging normal, Mobility decreased
Clinical narrative: loss of speech; elevated blood pressure; paralysis (hemiplegia) of the right side of my body; full body weakness; This is a spontaneous report from a contactable consumer (patient). A 42-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration, in left arm on 17Apr2021 15:00 (at the age of 42-years-old) as 1st dose, single dose for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was hospital. Device date reported 09Jun2021. Medical history was not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. Known allergies were reported guava's, latex, covid-19 vaccine (MRNA, Bnt162b2, Lnp-S), diphenhydramine, ketorolac, prochlorperazine. Concomitant medications included cetirizine and hydroxyzine both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any vaccines within four weeks prior to the vaccination. On 17Apr2021 15:15, the patient experienced extreme and debilitating symptoms including paralysis (hemiplegia) of the right side of his body, full body weakness, loss of speech and elevated blood pressure that have been present and persisting since immediately following his first dose. Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, disability, or permanent damage. 08 days of hospitalisation were reported. Treatment received for the adverse event was blood pressure medications and PT. The patient underwent lab tests and procedures which included Covid-19 RNA, qualitative (M2000) nasal swab, negative on 18Apr2021, POCT COVID-19 RNA, Qualitative, nasal swab negative on 18Apr2021, COVID19 RNA, QUALITATIVE(M2000), nasal swab negative on 22Apr2021 and POCT COVID-19 RNA, Qualitative, nasal swab negative on 15May2021.The outcome of events was Not recovered .  Information on Lot/Batch number was available. Additional information has been requested